Detailed Notes on Hypersensitivity Types and Diagnostic Methods

Allergen extracts are tested using coated nitrocellulose strips in a specialized cassette, where a finger prick blood sample from the patient is applied. This type of testing is rapid and provides preliminary results regarding sensitization to specific allergens. A colored line appearing in the allergen zone signifies the presence of allergen-specific IgE antibodies, indicating that the patient has been sensitized to the allergen in question. It’s important to note that while a positive result suggests sensitization, it does not necessarily confirm a clinical allergy; this requires further evaluation, including detailed consideration of the patient’s medical history, symptoms, and possibly additional testing.

In Vitro Tests: Total IgE

Total serum IgE tests are utilized to measure overall IgE levels in the bloodstream. Traditionally, the competitive radioimmunosorbent test (RIST) was the primary method for performing these tests. However, this technique has largely been supplanted by noncompetitive assays, which are more cost-effective and less complex. Noncompetitive assays work by binding anti-human IgE antibodies to a solid phase, followed by the application of enzyme-labeled anti-IgE antibodies to detect the IgE that has bound to the solid phase.

Total IgE values are reported in kilo international units (IU) per liter (kU/L), and it's critical to understand the reference ranges. For context, key measurements indicate that 1 IU equals approximately 2.4 ng/mL. Total IgE levels are also subject to variation with age; newborns typically exhibit low levels, while adult levels tend to stabilize around the age of 10. Notably, levels exceeding 100 kU/L can indicate potential allergies, although this is not definitive without correlating clinical data.

Limitations of Total IgE Testing

It is imperative to recognize the limitations of total IgE testing: these tests are not reliably diagnostic for allergies due to the wide variance in IgE levels across different individuals and over time. Specific IgE tests, targeting particular allergens, are preferred for confirming allergy diagnoses. While total IgE levels can provide insights into other medical conditions — for example, elevated levels may be associated with helminthic infections or immunodeficiencies — they should not be solely relied upon for allergy identification. Furthermore, children residing in endemic areas may present with total IgE levels exceeding 1,000 kU/L, and conditions such as hyper-IgE syndrome can result in levels reaching up to 50,000 kU/L, complicating the clinical picture even further.

Type II Hypersensitivity

Type II hypersensitivity is characterized by the involvement of IgG and IgM antibodies that specifically target antigens present on the surfaces of cells. The consequences of antibody-antigen interactions in this hypersensitivity include:

  1. Cell Destruction: Direct damage to target cells by antibodies leading to cell lysis.

  2. Inhibition of Function: Antibodies may inhibit normal function of the cell, which can disrupt physiological processes.

  3. Stimulation of Function: Some antibody bindings can enhance or trigger abnormal cellular activities.

Mechanisms of Cell Damage

The mechanisms by which cell damage occurs in Type II hypersensitivity include:

  • Complement Activation: This process can result in cell lysis through the formation of membrane attack complexes.

  • Opsonization: The binding of antibodies enhances phagocytosis, facilitating the clearance of affected cells by macrophages.

  • Antibody-Dependent Cellular Cytotoxicity (ADCC): IgG antibodies engage immune effector cells such as macrophages and natural killer (NK) cells, promoting their cytotoxic action against the target cells.

Clinical Examples

  1. Blood Transfusion Reactions: These reactions occur when antibodies present in the recipient's serum target foreign antigens on transfused red blood cells (RBCs). The primary blood groups involved are ABO and Rh systems. Symptoms can range from mild allergic reactions to severe hemolytic crises, necessitating careful crossmatching prior to transfusions.

  2. Hemolytic Disease of Newborn (HDN): HDN occurs when maternal IgG antibodies cross the placenta and target fetal RBC antigens, resulting in destruction of the fetal RBCs. This condition is most commonly associated with the D antigen of the Rh blood group system. Administration of anti-D immune globulin (Rhogam) to Rh-negative mothers can prevent the development of HDN during subsequent pregnancies.

  3. Autoimmune Hemolytic Anemia: In this disorder, patients develop antibodies against their own RBCs, leading to their destruction. It can be categorized based on temperature sensitivity into warm-reactive or cold-reactive types. Treatment approaches may include corticosteroids for inflammation reduction and splenectomy in severe cases.

Type III Hypersensitivity

Type III hypersensitivity involves the formation of immune complexes from soluble antigens and antibodies, which then get deposited in various tissues. This deposition triggers complement activation and inflammation. A classic example of this phenomenon is the Arthus reaction, where localized inflammatory responses occur following reintroduction of an antigen to sensitized individuals. The resulting inflammation can cause edema and, in severe cases, necrosis due to immune complex accumulation in blood vessels.

Testing for Type II and III Hypersensitivities

Coombs’ Tests: These consist of direct and indirect assays used to detect antibodies either on the surface of RBCs or in their free forms, serving a critical role in ensuring transfusion safety. They are particularly valuable in identifying and managing autoimmune hemolytic anemias and ensuring the safe administration of blood products during transfusion.